Last reviewed · How we verify

NCT05801861

Modulating Goal-directed Navigation Using Noninvasive Brain Stimulation

Recruiting now NA Last updated 17 November 2025
What this trial tests

NA trial testing Active 10-Hz TMS to the parietal cortex in Spatial Navigation in 60 participants. Currently enrolling.

Timeline
24 March 2023
Primary endpoint
31 August 2026
31 August 2026

Quick facts

Lead sponsorRutgers, The State University of New Jersey
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposebasic science
Enrollment60
Start date24 March 2023
Primary completion31 August 2026
Estimated completion31 August 2026
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Rutgers, The State University of New Jersey

Who can join

Adults 18 to 55, any sex, with Spatial Navigation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our specific aim is to examine the effects of TMS on spatial processing during goal-directed navigation. In these experiments the investigators will utilize a scalp-recorded brain oscillation called right posterior theta that is believed to index the sensitivity of the parahippocampal cortex to spatial context. Here the investigators will asked whether this electrophysiological signal can be modulated up or down using TMS while participants engage in virtual navigation tasks, and if so, whether it would affect the spatial encoding of rewards and subsequent choices during task performance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Spatial Navigation

Currently open trials in the same condition.

Other Rutgers, The State University of New Jersey trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05801861.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing